External Ventricular Drain Market To Reach $3.26 Billion By 2033

External Ventricular Drain Market Growth & Trends 

The global external ventricular drain market size is anticipated to reach USD 3.26 billion by 2033, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.29% from 2026 to 2033. High incidence of hydrocephalus and subsequent increase in the number surgical procedure to treat this condition are driving the market. An external ventricular drain also known as ventriculostomy is a medical procedure performed to remove excess cerebrospinal fluid from the ventricles of the brain to maintain intracranial pressure. It is used for conditions such as severe head injury, hydrocephalus, intracranial hypertension, subarachnoid hemorrhages, and inflammatory diseases of the cerebrospinal space.

Rising prevalence of cerebrovascular disorders and traumatic brain injuries globally is leading to the increased demand for external ventricular drain, thereby propelling market growth. According to the Stroke Statistics 2018, over 100,000 people suffer from strokes in the U.K. every year. Out of which around 85.0% are ischemic strokes and 15.0% are haemorrhagic, which results in the blocking of blood flow to the brain.

Furthermore, incorporation of various modern technologies, and introduction of new products by market players, are likely to boost the market during the forecast period. For instance, in September 2017, Arkis BioSciences received U.S. FDA approval for its “CerebroFlo”- an external ventricular drainage catheter. It is used for insertion into ventricular cavity for external drainage of cerebrospinal fluid.

 Request a free sample copy or view report summary: External Ventricular Drain Market Report

External Ventricular Drain Market Report Highlights

• Based on application, the traumatic brain injury dominated the external ventricular drain market in 2025, driven by the rising incidence of road traffic accidents, falls, and sports-related head injuries worldwide.

• North America dominated the market for external ventricular drain with a revenue share of 54.47% in 2025. This is owing to the greater incidence of traumatic brain injuries in the region, as well as a high prevalence of neurovascular disorders.

• The pediatric segment is expected to grow the fastest during the forecast period. The rising incidence of congenital hydrocephalus and neonatal brain injuries drives this growth.

External Ventricular Drain Market Segmentation 

Grand View Research has segmented the global external ventricular drain market report based on product, patient type, end use, and region:

External Ventricular Drain Application Outlook (Revenue, USD Million, 2021 - 2033)

• Traumatic Brain Injury

• Subarachnoid Hemorrhage

• Intracerebral Hemorrhage

• Other Non-traumatic Hydrocephalus Conditions

External Ventricular Drain Patient Type Outlook (Revenue, USD Million, 2021 - 2033)

• Adult

• Pediatric

External Ventricular Drain End Use Outlook (Revenue, USD Million; 2021 - 2033)

• Hospitals

• Others

External Ventricular Drain Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Sweden

  • Denmark

  • Norway

  • Germany

  • UK

  • France

  • Italy

  • Spain

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of External Ventricular Drain Market

• Spiegelberg GmbH & Co. KG (Luciole Medical AG)

• Medtronic

• Sophysa

• Natus Medical Incorporated

• Neuromedex GmbH

• Integra LifeSciences

• Möller Medical GmbH ( Centrotec Sustainable AG)

• B. Braun SE

• Fuji Systems